UK MHRA: Gene Therapy Manufacturing Methods Need ‘Urgent Harmonization’

 
• By Eliza Slawther
  
Caption CRISPR-Cas9 gene editing poses a major safety concern for regulators (Shutterstock)

More from Cell & Gene Therapies

More from Advanced Technologies